Sabby Management, LLC Vista Gen Therapeutics, Inc. Transaction History

Sabby Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$0.85 - $1.5 $121,963 - $215,229	-143,486 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$0.91 - $1.73 $1.79 Million - $3.41 Million	-1,972,387 Reduced 93.22%	143,486 $133,000
Q4 2017 Feb 14, 2018	BUY	$0.72 - $2.03 $1.52 Million - $4.3 Million	2,115,873	2,115,873 $2.35 Million

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.